Literature DB >> 27768303

Design, Synthesis, and Structural Characterization of a Bisantimony(III) Compound for Anion Binding and the Density Functional Theory Evaluation of Halide Binding through Antimony Secondary Bonding Interactions.

Jinchun Qiu1, Daniel K Unruh1, Anthony F Cozzolino1.   

Abstract

Density functional theory calculations were used to design an anion receptor that utilizes antimony(III) secondary bonding interactions. Calculations were performed on promising motifs found in the chemical literature where two antimony sites were found in close proximity to a halide anion. The study was extended to a structurally related class of 1,3,2-benzodioxastibole derivatives to elucidate their potential for binding halide ions. Multiple geometric conformations were evaluated and various ratios of halide anions were considered. According to the computation results, this class of anion receptors shows strong affinities toward charge-dense halides. These 1,3,2-benzodioxastibole derivatives were prepared to evaluate their synthetic accessibility. Structural characterization of one species revealed the ability to bind up to three electron donors through secondary bonding interactions. This gates the future experimental study of these antimony systems for anion binding and recognition.

Entities:  

Year:  2016        PMID: 27768303     DOI: 10.1021/acs.jpca.6b08170

Source DB:  PubMed          Journal:  J Phys Chem A        ISSN: 1089-5639            Impact factor:   2.781


  2 in total

Review 1.  On the Importance of Pnictogen and Chalcogen Bonding Interactions in Supramolecular Catalysis.

Authors:  Antonio Frontera; Antonio Bauza
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

2.  Binuclear Triphenylantimony(V) Catecholates through N-Donor Linkers: Structural Features and Redox Properties.

Authors:  Andrey I Poddel'sky; Ivan V Smolyaninov; Aleksandra I Shataeva; Evgenii V Baranov; Georgy K Fukin
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.